Abstract -The honey bee is a key non-target arthropod in environmental risk assessments of genetically modified crops. We analyzed for the first time combined effects of three Bt proteins conferring insect resistances, and a CP4-protein conferring an herbicide resistance as simultaneously expressed in one GM maize. Furthermore, the biosafety of Galanthus nivalis agglutinin (GNA lectin), a candidate protein for pest control was tested. Under worst-case exposure scenario, by using controlled in vitro larvae rearing, the combination of Bt proteins showed no adverse effects on bee larvae. In contrast, the GNA lectin was toxic at a 144 h LD 50 of 16.3 μg/larva. The prepupal weight was found to differ between the larvae collection days and between the colonies used for the experiment, explaining up to five times more data variance than the protein treatments (N=709 prepupae). In conclusion, neither single nor a mix of different Bt proteins were found harmful to honey bee larvae.
INTRODUCTION
The Western honey bee (Apis mellifera L.) is a main pollinator species of agricultural crops and wild plants worldwide (Klein et al., 2007; Potts et al., 2010) . By feeding on pollen and nectar, honey bees can be exposed to insecticidal proteins expressed by genetically modified (GM) crops (Duan et al., 2008; Romeis et al., 2008; Malone and Burgess 2009) . Transgenic gene products expressed in insect-resistant GM crops can confer protection against specific herbivorous pest insects. In particular, the expression of Cry proteins derived from the bacterium Bacillus thuringiensis (Bt) is increasing in commercially cultivated GM crops (James, 2010) . Cry proteins typically affect the larvae of susceptible holometabolous insects by a lethal damage to the peritrophic membrane within the gut (De Maagd et al., 2001) . Recent developments in crop biotechnology focus on multi-insect-resistant crops with high expression levels, producing a number of different insecticidal proteins at the same time (James, 2010) . In general, the stacking of traits in one event aims to enhance the protection against target pest insects by causing additive or synergistic Electronic supplementary material The online version of this article (doi:10.1007/s13592-012-0123-3) contains supplementary material, which is available to authorized users. toxicity effects (Wolt, 2011) . Target lepidopteran pest insects are reported to be synergistically affected by the different combinations of Cry1Ab, Cry1Ac, Cry1F and/or Cry2Ab2 (Lee et al., 1996; Stewart et al., 2001; Khasdan et al., 2007; Sharma et al., 2010) .
Pollen is the main protein source for honey bees. A colony can accumulate up to 55 kg of pollen per year (Seeley, 1985) , and nurse bees consume 3.4 to 4.3 mg of pollen per day (Crailsheim et al., 1992) . Most of the pollen is used to produce food for the larvae in their hypopharyngeal gland, but it was shown that nurse bees do not pass Bt proteins on to larvae via their food secretions (Babendreier et al., 2005) . Thus, the exposure of Bt protein to larvae is limited to direct pollen feeding, which was found to be about 2.0 mg for maize pollen per larva during their development time (Babendreier et al., 2004) . It thus appears that exposure of larvae towards transgenic products is lower than for adult bees. However, larval stages generally show a higher susceptibility to Bt proteins than adults, with neonate larvae being more sensitive than older larval instars (Glare and O'Callaghan 2000; Yao et al., 2008) . Hence, we follow the idea of testing the potentially most sensitive life history stage for Bt proteins (Romeis et al., 2011) , i.e., honey bee larvae.
Bt crops expressing single Cry proteins were not found to impact honey bees during a recent meta-analysis (Duan et al., 2008) . However, no studies assessing the risk of simultaneously expressed Cry proteins on honey bees have been conducted until now. To assess the biosafety of pollen-rewarding transgenic crops with multi-insect resistances, the protein expression of a stacked Bt maize variety "Mon89034× Mon88017" was taken as a reference model. Combined effects of four transgenic proteins were tested individually, and in combinations that are proportional to the expression levels in stacked Bt pollen: Cry1A.105, Cry2Ab2, Cry3Bb1 against major lepidopteran and coleopteran pest insects and the CP4 EPSPS protein conferring herbicide resistance. The arthropodactive protein lectin Jaber et al., 2010) was also tested for toxic effects on honey bees since it is a future pest control candidate for expression in, e.g., maize and rapeseed.
We used a concentration gradient which exceeds the estimated environmental concentration (EEC) by a multifold, and performed experiments that took into account protein interactions, the colony background of test individuals, thereby effectively monitoring honey bee biosafety.
MATERIAL AND METHODS

In vitro larvae bioassay
The rearing of larvae was performed under controlled laboratory conditions following the methods of Aupinel et al. (2007) and Hendriksma et al. (2011a) (Supplement P). These methods were adopted to test for the first time effects of mixed transgenic proteins on in vitro-reared larvae. The test larvae originated from six donor honey bee colonies with naturally mated non-sibling queens (A. mellifera carnica). On June 23 and 25, 2009, queens were trapped on artificial combs within their colonies (Cupularve, Nicoplast©, Maisod, France). We further refer to the material and methods section in Hendriksma et al. (2011a) , for the first-instar larvae collection (D4; age mean 10:29 hours) and the details of in vitro rearing (D5-D9).
The larvae finished their in vitro diet at day 10 and actively stopped digestion by a molt and defecation of the intestinal tract, which terminated the exposure to ingested products. By day 11, the larvae were stretched and passive, which is indicative for the prepupae phase. To assess lethal effects, the survival of larvae was noted daily, and moribund larvae were removed, as recognized by occasional black or white sub-dermal necrotic stains or a visible loss of turgor. Potential sublethal effects were monitored on day 11, by weighing each prepupa on an analytical microbalance to the nearest 0.001 g (Hendriksma et al., 2011a) .
To reflect transgenic protein exposure by GM pollen consumption, eight treatments were established by mixing different proteins into the semiartificial diet of second-instar larvae on day 5. The diet was ingested by the larvae during the subsequent days. All protein treatments were made up to account for a concentration gradient (Table I ). The bioassay was conducted with larvae, which were sampled on two successive days (N=755 larvae). Considering the different colony backgrounds, the larvae were equally distributed over the concentration gradient within each treatment, with mean 18 replicate larvae per individual treatment dose.
Protein treatments
The Bt protein resistances by Cry1A.105 and Cry2Ab2 target a wide range of common lepidopteran pests (e.g. armyworms Spodoptera sp., black cutworm Agrotis ipsilon, corn borers, e.g., Ostrinia nubilalis and corn earworms, e.g., Helicoverpa zea). Cry3Bb1 confers resistance against coleopteran pests like the western, northern, and Mexican corn rootworms Diabrotica spp. (Coleoptera: Chrysomelidae). A non-insect-related protein EPSPS of Agrobacterium sp. strain CP4 was tested as transgenic protein conferring resistance to glyphosate, the active ingredient of the herbicide Roundup.
For each protein, a stock diet was made with a maximum treatment dose, of which an exponential concentration gradient was made by repetitively diluting each stock solution with basic diet with the factor 1/ 10. All the diets were made on the first day of larval collection, stored at 6°C, and warmed up to 35°C before application. The stock diets with the transgenic proteins were made by a replacement of the water fraction in the diet with buffer solutions containing the purified transgenic proteins (obtained from Monsanto company, St. Louis, USA and stored at −80°C preceding application). Table I ). The Lepidoptera active Cry proteins were verified on toxicity (Aglais urticae; pers. comm. Schuppener, RWTH Aachen).
Buffer chemicals may cause effects on larvae as well, thus zero concentration controls for transgenic protein treatments were diets with buffer solution [B1/ B2/B3/B4/Bmix] ( Table I ). The mixed buffer treatment [6] is the direct control of the stacked protein treatment [5] , containing the identically proportioned buffer mix. Bovine serum albumin (BSA) was applied as a noninsecticidal protein control [7] : maximally 8% solid protein (w/w). Additionally, snowdrop lectin (GNA; Galanthus nivalis L. agglutinin) was used as another class of transgenic pest control proteins [8] (Romeis et al., 2003; Babendreier et al., 2008) at maximally 0.8% (w/w) solid protein ( Table I ). The buffer chemicals and the two control proteins were ordered at SigmaAldrich Chemie Gmbh, Munich, Germany.
Statistics
Four variables of possible influence on the data were considered: eight treatments, one gradient, six colonies, and two trials (larval sampling days). The concentration gradient with the dosage levels d×10 -6] were all in proportion to each other, reflecting the transgenic protein concentrations within stacked Bt pollen. Larval survival and prepupae weight were the tested response variables; the dose-response tests were performed by regression over the concentration gradient. By the use of the interaction term treatment×gradient, treatment-specific dose-response effects could be compared. All variables and all meaningful interactions were tested and successively rejected from the models when they were insignificant (α=0.05). For all post hoc tests, such as in the comparison of one treatment with seven other treatments, the significance of P values was determined at α=0.05, applying Bonferroni corrections on the P values for the number of comparisons. The survival of larvae was analyzed with proportional hazards regression models (Coxph: Cox and Oakes 1990; Fox 2002 ) using the open-source statistic software R, version 2.11.1 (R Development Core Team, 2010) . This regression on survival dynamics over time can take multiple explanatory variables into account, and has the option to include a random factor to correct for non-independence within the dataset (Zuur et al., 2009; Hendriksma et al., 2011a) (Table IIA) . In case of Table I . Feeding treatments of in vitro-reared honey bee larvae for Bt protein bioassays. toxicity, LD 50 values were calculated, taking into account the colony dependence of test individuals (Hendriksma et al., 2011a) , with 95% confidence intervals determined by Fieller's method (Finney, 1971; Niu et al., 2011) . The prepupae weight analysis was performed using linear models (lm: Chambers, 1992 , Anova type III) to measure treatment, colony, gradient, and trial effects (Table IIB) .
RESULTS
Survival rates
The three tested Bt proteins Cry1A.105 (n= 109), Cry2Ab2 (n=110), Cry3Bb1 (n=109) [treatments 1-3] did not show insecticidal effects on developing honey bee larvae, with survival rates between 95.5% and 100% per test gradient (Table III) ([5] 97.8%, n=92) the survival was high, and remained unaffected even at the highest concentration tested (Figure 1 ).
The buffer mix [6] with 96.6% survival was not significantly different from the five transgenic protein treatments (χ²≤5.0, P value≥ 0.18). With mean mortality rates of ≤7.5%, no treatment-specific dose-response effects were found within the tested groups [1-7] (χ²≤1.17, P value≥0.19, Table III ).
In contrast, GNA lectin [8] showed a significant increase in larval mortality over the concentration gradient (Supplement S: R²=0.52, χ 2 =67.0, P< 0.001, n=93). GNA lectin [8] killed all test larvae at the highest dose of 5‰ w/w (LT 100 =144 h; n= 20; Figure 1) . The 96 and 144 h LD 50 values were indicated 39.1 and 16.7 μg dietary lectin protein per larva respectively (with 95% CI's 30.4-51.9 and 13.5-20.8 μg/larva, respectively). A post hoc test over all treatments, and an additional test on the highest applied doses only (Figure 1 ), confirmed that lectin was the only treatment causing mortality (Table III) . It is important to note that the experiment had a low residual background mortality of mean 3.5% (26/735 larvae; excluding the highest dose of the lectin treatment).
Neither the colony background of test organisms (χ² =3.59, d.f. =5, P= 0.61) and their potential interaction with treatments (χ²=37.0, d.f.=35, P=0.38), nor the two trials (χ²=0.70, d.f.=1, P=0.40) were found to affect survival of honey bee larvae. Only the treatment×gradient Honey bee larvae bioassays on GM crop proteins interaction was found to be significant, driven by lectin [8] as sole discriminate treatment (post hoc P values<0.001; Supplement S).
Prepupae weights
The mean prepupal weight was in range of 138.9 to 143.6 mg (Supplementary Table S) , showing no differences between treatments (P= 0.66; Table IIB ). The applied factor gradient did not affect prepupal weight (P=0.08; Table II B) , showing the absence of dose-related effects within treatments (Figure 2 ; post hoc P>0.13). However, between treatments dose-response differences were present (P=0.008; Second-instar larvae were exposed to a protein dose within their diet (D5) and monitored for survival of test individuals up to the prepupae stage where larvae finish eating and growing (D11). The tabulated statistics for the gradient were based on individual treatment subsets. Color coding is used to visualize potential patterns in mortality (white 0%, light gray <10%, dark gray >10%, black 100% mortality) P value significances are based on an α-level of 0.05 ***P<0.001
Within the prepupae weight data, no explanatory variable, nor any interaction between variables, substantially contributed to the explanation of variance (R 2 ≤0.026, Table IIB) . Finally, a low weight of prepupae was not found to correlate with a higher larval mortality rate (F (1, 40) =0.16, P=0.69; R²=0.004).
DISCUSSION
Toxicity of Cry proteins and CP4
The cultivation of GM crops with insect resistances requires comprehensive biosafety assessments, with robust and highly standardized bioassays for main non-target organisms. We used a sensitive and well suited in vitro larvae-rearing method to study single and multiple insect-resistant Bt crop effects on the main pollinator A. mellifera. The three tested purified Bt proteins, expressed in the pollen of the reference maize variety "Mon89034 × Mon88017" did not affect survival rates and weight gain of second-instar larvae, even at Bt toxin amounts exceeding a normal 2 mg Bt maize pollen EEC by 186 times. Thus, stacking of three Bt toxins showed no lethal or sublethal effects on honey bee larvae. Nonetheless, unknown subtle Bt effects may have remained unrevealed by this study.
Our tested Cry1A.105 toxin is a "chimeric" protein, developed by recombining cry1Ac, cry1F, and cry1Ab genes of different B. thuringiensis strains. Compared to the native proteins, chimeric proteins are designed to have an increased toxicity and have a broadened range of target pest insects (Pardo-López et al., 2009; Pigott et al., 2008) . Regulatory agencies may omit additional biosafety tests on chimeric proteins, if and when the predecessor proteins were assessed to be safe. However, as reduced selectivity and increased toxicity may not only affect target insects but also non-target insects, extrapolating risks of novel chimeric proteins based only on the data of the predecessor proteins could be misleading. Nevertheless, our data show that this chimeric Cry1A.105 protein is not directly harmful to A. mellifera larvae.
Recently conducted pollen feeding trials, in which in vitro-reared third-instar larvae were exposed to 2 mg pollen of the Bt maize variety "Mon89034 × Mon88017" during 5 days, showed 100% survival (Hendriksma et al., 2011b) and thus are fully in line with results from worst-case exposure scenarios obtained in the present study. Similarly, the overall mean weight of prepupae and also mean prepupal weight at the highest applied purified protein doses are in perfect range with the pollen feeding test (Hendriksma et al., 2011b) . Our results on single Bt proteins further complement the less standardized colony level studies on single Cry1Ab or Cry1F maize pollen (Hanley et al., 2003) and the purified Cry3B protein (Arpaia, 1996) , for which also no deleterious effect by Cry protein were found on honey bee Figure 2 . Prepupal weight of protein exposed larvae (n=709). Dose-response effects of transgenic proteins on the prepupae weight of in vitro-reared honey bee worker larvae are shown. Dotted lines indicate non-significant dose-response result for each treatment at increasing concentrations (for treatment details see Table I and for  statistics Tables IIB and IV ) . Note that at the highest lectin concentration, all test individuals had died (tilde).
Honey bee larvae bioassays on GM crop proteins brood. A recent in vitro study on the effect of purified Bt protein Cry1Ac (50 μg) on Africanized honey bees reported no effect on larval survival rates, development time, or adult body mass (Lima et al., 2011) . Together with our results on Cry1A.105 and earlier studies, a high Cry1 protein safety range for A. mellifera larvae can be confirmed. While numerous studies have been conducted on Cry1 Bt toxins, few studies have been done on Cry3 Bt toxins and hardly any on potential risks of Cry2 Bt toxins on bees (Malone and Burgess, 2009 ). Thus our results add valuable information here.
Similar to the results obtained for single Bt proteins, the transgenic mix of proteins as expressed in Bt pollen [5] did not affect larval survival or prepupal weight, not even at the highest concentration doses applied. Two observed dose-response differences, with CP4 [4] and the protein mix [5] showing contrasting responses in comparison to Cry2 [2], were not substantiated by individually significant doseresponse effects. In addition, the biological nontoxicity of all applied transgenic treatment concentrations has been underlined by very low explanatory values (≤2.6%; Table IIB), and the fact that the protein treatments [1-5] did never differ from the buffer control [6], or BSA [7] as non-toxic control. We conclude that the observed treatment differences were biologically irrelevant.
In general, the stacking of traits in one event aims to enhance the protection against target pest insects by causing additive or synergistic toxicity effects (Wolt, 2011) . The uptake, transportation or degradation pathways within organisms are commonly involved at toxicant synergies (Andersen and Dennison, 2004) . This typically addresses the mode of action of Bt proteins, disrupting the intestinal systems of target arthropods. Target pest insects are reported to be synergistically affected by combinations between Cry1Ab, Cry1Ac, Cry1F and/or Cry2Ab2 (Lee et al., 1996; Stewart et al., 2001; Khasdan et al., 2007; Sharma et al., 2010) . If susceptible to Bt proteins, even to a small extent, non-target organisms need consideration on synergistic toxicity issues. However, the data presented here do not support any susceptibility of honey bee larvae to any of the three Cry toxins tested. Consequently, in our case study on mixed Bt effects on bees, additional mixed toxicity evaluations were regarded as irrelevant (e.g. testing on additivity of effects, or on synergistic or antagonistic effects). Our findings corroborate recent statements from EFSA that interactions among Cry1A.105, Cry2Ab2, Cry3Bb1, and CP4 EPSPS are unlikely, based on the known function and mode of action of these proteins (EFSA, 2010) .
New to honey bee risk assessment is the testing of a purified transgenic CP4 EPSPS protein, both singly and mixed with the three Bt toxins like it would appear in the transgenic maize event. The Agrobacterium sp. strain CP4-derived EPSP synthase is tolerant to the herbicide glyphosate (Padgette et al., 1995) . Because it replaces the intolerant synthase, CP4 EPSPS enables continuation of amino acid biosynthesis after glyphosate herbicide treatment of plants (Steinrücken and Amrhein, 1980) . Neither a mechanism, nor evidence exists that the CP4 EPSPS protein is harmful to animals, plants, or other life forms (Peterson and Shama, 2005) . Our results further indicate that the CP4 protein does not pose a risk to pollinating insects when it is expressed in pollen of transgenic plants.
A number of Bt crops are assessed safe for A. mellifera, apparently due to missing receptors for the respective Bt toxins (Duan et al., 2008; Malone and Burgess, 2009) . Even a hymenopteran-active Bt strain (PS86Q3; active to sawflies Diprion pini and Pristiphora abietin) was not found to affect honey bee larvae (Porcar et al., 2008) . Nevertheless, a case by case risk assessment on future Bt crops is mandatory, since Bt products yet to be developed may pose new risks to bees (Romeis et al., 2006) .
Lectins
In contrast to all other treatments, snowdropderived lectin (GNA) elicited mortality of all larvae at the highest concentration level (0.8% w/w in 10μL diet, 0.08 mg per larva). This could be relevant for honey bees because GNA is regarded as a candidate for expression in transgenic crops like maize and rapeseed to confer resistance against pest insects (e.g. Romeis et al., 2003; Lehrman, 2007; Babendreier et al., 2008) . In comparison, 1.0% GNA mixed into sucrose solution fed to the parasitic Hymenopterans Aphidius colemani, Trichogramma brassicae, and Cotesia glomerata, also reduced the survival of test individuals by 58%, 39%, and 56%, respectively (Romeis et al., 2003) .
A dietary pollen feeding test (1.5% w/w) expressing transgenic pea lectin up to 1.2% of total soluble protein in oilseed rape pollen, revealed no negative effect on honey bee larvae (Lehrman, 2007) , which is likely due to the relative low quantity of protein exposed. At the dose of 0.08% GNA in the diet, we found no lethal effects and also no indication of a sublethal inhibition of larval feeding. This result contrasts to mason bee larvae Osmia bicornis, which showed an inhibited food intake and had a reduced survival at 0.1% GNA in the diet (Konrad et al., 2008) . Similarly, 0.1% GNA mixed into sucrose solution and fed to bumblebee Bombus terrestris workers and drones also showed reduced survival rates . A similar lectin (wheat germ agglutinin; WGA) was described affecting adult honey bee midgut esterase and protease activity at 0.1% WGA feeding (Belzunces et al., 1994 ).
An explanation for not finding sublethal effect at 0.08% (8 μg/10 μL) is that abovementioned studies fed the concentration constantly, while in the present study the honey bee larvae were exposed to it in one dietary application. In this case, an assumption of chronic exposure would better fit our data to the other mentioned studies; No effects at 0.005% [8 μg GNA/total 160μL diet], and all individuals dead at 0.05% [80 μg GNA/160 μL].
In general, for potential GM crops expressing lectins, the risk will depend very much on the exposure levels Malone and Burgess, 2009) . Despite the fact that lectin-expressing GM crops are not commercialized, bees may already be exposed to lectins . Leek (Allium porrum) nectar can contain 0.02% of a mannose-binding lectin, similar to GNA (Peumans et al., 1997) . As this concentration lies close to the effect range of about 0.1% as recorded in the above-mentioned studies, a potential insecticidal risk is not excluded. Thus, risks of transgenic plants expressing lectins for honey bees need to be addressed for all melliferous, as well as all polleniferous crops. The overall mean weight per treatment is given (with the standard deviation). Indicated in the matrix are mean prepupae weights per treatment dose. The gradient follows the exponentially increasing low dose "d". The range of effects per treatment is indicated with a light gray shade for minima values and a dark gray shade for the maxima values. Symbol " †" indicates that all test individual have died (at the highest level of lectin) for which no data on the weight of prepupae available Honey bee larvae bioassays on GM crop proteins
Methodological strength
In comparison to the reported 19% background mortality at testing Cry1Ab over the arval phase by Lima et al. (2011) , the 0% mortality for Cry1A.105 fed larvae (n=105), and a 3.5% general background mortality is a notable improvement for environmental risk assessment studies. The low mortality rate is linked to the non-grafting approach where minimizing contact with the larvae allows to optimize rearing success (Supplement P; Hendriksma et al., 2011a) .
We started the Bt protein applications at the second-instar stage to reflect the natural exposure pathways in honey bees. This includes a safety margin, since exposure for young larvae is negligible because pollen are only in the larval food from the third-instar stage onwards (Simpson 1955 , Jung-Hoffmann 1966 and Bt protein is not secreted via nurse bee feeding glands (Babendreier et al., 2005) . Hive experiments reported similar weights of prepupae but revealed higher weight ranges (Babendreier et al., 2004) . They found mean weights of 132 to 155 mg for fully grown larvae (Δ23.0 mg), also with a significant difference among colony backgrounds. This proves the in vitro bioassay to produce data in a representative range, with all level means in the range of the empirical data (Table IV) .
The general question of whether laboratory studies on transgenic insecticidal crops can be extrapolated to the field situation has been recently addressed by Duan et al. (2010) . They showed that indeed laboratory studies on GM crops show effects that are either consistent with, or more conservative than, those found in field studies, provided that ecologically relevant routes of exposure have been addressed properly. Since we here have included a wide range of concentrations including worst-case scenarios, it is concluded that our results are likely conservative, leaving a safety margin.
CONCLUSIONS
Under worst-case exposure scenarios, Bt proteins Cry1, Cry2, and Cry3 and the CP4-protein were not found to be toxic to developing honey bee larvae, and mixed toxicity effects were not indicated. The results presented in our case study on developing honey bee larvae extend the biosafety of single Bt proteins to multiple Bt proteins. In contrast, GNA lectin caused acute mortality among larvae, stressing the risk for beneficial insect pollinators in the agricultural landscape when GNA would be expressed in melliferous and/or polleniferous GM crops.
